FDA Approves Unknown Drug — LUPIN

# FDA Approves Lupin's Generic Drug Application Lupin Limited received FDA approval for its abbreviated new drug application (ANDA 216095), expanding the company's generic portfolio and positioning it to capture additional market share in the competitive U.S. generics sector. The approval strengthens Lupin's commercial footprint and is expected to contribute to revenue growth as the company launches the newly approved generic medication.